南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

通过掩蔽的腺相关病毒载体实现可控基因递送

Controllable gene delivery via masked adeno-associated viral vectors

Zeng Zhiying, Chang Liying, Wang Jingjing, Liu Yingze, Wang Xin, Sun Yi, Zuo Yi, Hou Xiaoyu, Wang Yong, Gu Zhen, Liu Tao

Journal:NATURE MATERIALS

IF:38

DOI:10.1038/s41563-026-02724-1

PMID:42811129

Published:2026-09-29

research field:基因治疗可控释放蛋白质工程病毒载体靶向递送

Abstract

Controllable gene delivery to specific tissue by adeno-associated viruses (AAVs) is a challenge in gene therapy. Here we develop masked AAVs, whose transduction is blocked and restored only on pathological activation or by activation triggered by exogenous signals. The masking effect is accomplished by genetic encoding of non-canonical amino acid with tetrazine groups into AAV capsid proteins, allowing efficient reaction with trans -cyclooctene-modified truncated AAV receptor or polyethylene glycol to completely block viral infectivity in mice. With three different cleavable linkers, masking groups are selectively removable through liver-specific protease matriptase-2, near-infrared light or inflammation-associated reactive oxygen species, thus restoring the infectivity of AAVs and allowing localized transduction in mice. Systemic administration of protease-activated masked AAVs enables tissue-specific gene delivery to the liver, while administration of near-infrared-activated masked AAVs provides localized transduction in irradiated regions such as muscles and brain. Intravenous administration of reactive-oxygen-species-activated AAVs achieves targeted gene delivery to the myocardium in a cardiac ischaemia–reperfusion injury model, resulting in the localized expression of VEGF-A165 and myocardial repair.

本文使用的Yeasen产品

产品应用
购物车
客服
转染试用